Monogenic Diabetes
Gene: SLC19A2
Well established gene disease association for thiamine-responsive megaloblastic anemia syndrome where diabetes mellitus is part of phenotype
3 patients with neonatal diabetes and SLC19A2 variants (PMID: 22369132) one patient with infantile onset diabetes (PMID:35114785)Created: 30 Apr 2024, 1:54 a.m. | Last Modified: 30 Apr 2024, 1:54 a.m.
Panel Version: 0.52
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
thiamine-responsive megaloblastic anemia syndrome MONDO:0009575; neonatal diabetes mellitus MONDO:0016391; diabetes mellitus MONDO:0005015
Publications
Gene: slc19a2 has been classified as Green List (High Evidence).
Phenotypes for gene: SLC19A2 were changed from Thiamine-responsive megaloblastic anemia syndrome; MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUS AND SENSORINEURAL DEAFNESS ROGERS SYNDROME to thiamine-responsive megaloblastic anemia syndrome MONDO:0009575
Publications for gene: SLC19A2 were set to 26549656; 26839896
gene: SLC19A2 was added gene: SLC19A2 was added to Monogenic diabetes. Sources: UKGTN,Expert Review Green Mode of inheritance for gene: SLC19A2 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: SLC19A2 were set to 26549656; 26839896 Phenotypes for gene: SLC19A2 were set to Thiamine-responsive megaloblastic anemia syndrome; MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUS AND SENSORINEURAL DEAFNESS ROGERS SYNDROME